Add time:07/11/2019 Source:sciencedirect.com
ObjectiveTo evaluate the treatment effects of the IL-6R antibody tocilizumab and cyclophosphamide (CTX) in patients with Takayasu arteritis (TA) and explore the mechanism by analyzing their effects on various cytokines.
We also recommend Trading Suppliers and Manufacturers of (6R)-6-{[(2E)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (cas 187235-55-8). Pls Click Website Link as below: cas 187235-55-8 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View